Answers are grounded in this paper and cite their sources.
Review demonstrates CRISPR/Cas9 versatility for targeted genome engineering in living cells, highlighting broad translational applications beyond older nuclease tools.
Microbes use diverse defence strategies that allow them to withstand exposure to a variety of genome invaders such as bacteriophages and plasmids. One such defence strategy is the use of RNA guided endonuclease called CRISPR-associated (Cas) 9 protein. The Cas9 protein, derived from type II CRISPR/Cas system, has been adapted as a versatile tool for genome targeting and engineering due to its simplicity and high efficiency over the earlier tools such as ZFNs and TALENs. With recent advancements, CRISPR/Cas9 technology has emerged as a revolutionary tool for modulating the genome in living cells and inspires innovative translational applications in different fields. In this paper we review the developments and its potential uses in the CRISPR/Cas9 technology as well as recent advancements in genome engineering using CRISPR/Cas9.
No takes yet. Share an insight, caveat, or question.
Lone et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: